載入...
BRCA2 carriers with male breast cancer show elevated tumour methylation
BACKGROUND: Male breast cancer (MBC) represents a poorly characterised group of tumours, the management of which is largely based on practices established for female breast cancer. However, recent studies demonstrate biological and molecular differences likely to impact on tumour behaviour and there...
Na minha lista:
| 發表在: | BMC Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5594583/ https://ncbi.nlm.nih.gov/pubmed/28893223 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3632-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|